CONSULTING SERVICES AGREEMENT
Exhibit 10.28
This Consulting Services Agreement ("Agreement") is entered into as of January 15, 2024 ("Effective Date") by and between Board Advantage LLC, with an address of 000 Xxxxxxx Xxxx, Xxxxxxx Xxxxxxx, XX 00000 ("Consultant"), and Akari Therapeutics, Inc. located at 00 Xxxxxx Xxxxx Xxxx XX 0, Xxxxxx, XX 00000 ("Akari"). Consultant and Xxxxx are each referred to individually as a "Party" and together as the "Parties."
Akari is a biotechnology company focused on developing advanced therapies for autoimmune and inflammatory diseases. Xxxxx wishes to engage Consultant to provide Interim Chief Financial Officer services ("Services") upon request and, to that end, the Parties agree as follows:
1
To carry out the Services, Consultant may receive certain information proprietary to Xxxxx. Consultant agrees not to use such information to his own or any other party's advantage, and will not disclose to any person or entity any confidential information of Akari, including but not limited to financial data, customer lists, projects, economic information, systems, plans, procedures, operations, techniques, patent applications, trade secrets, know-how, inventions, technical data or specifications, testing methods, research and development activities, or marketing strategies. The foregoing non-disclosure does not apply to information that (i) is already in the possession of Consultant without obligation of confidentiality (as shown by written records not derived from Akari ), (ii) was in the public domain at the time it was disclosed to Consultant or subsequent to disclosure becomes part of the public domain through no fault of Consultant, (iii) becomes known to Consultant without restriction from a source other than Akari without breach of this Agreement and otherwise not in violation of Xxxxx 's rights, or (iv) is disclosed pursuant to a requirement of a governmental body, provided, however, that Consultant shall provide prompt notice thereof to enable Akari to seek a protective order or otherwise prevent such disclosure. Information shall not be considered to be in public domain simply because one or more of its component portions are in the public domain. Consultant will maintain the confidentiality of all protected health information (as that term is defined in the Health Insurance Portability and Accountability Act of 1996, Public Law 104-191, and its implementing regulations, 45 CFR Parts 160, 162 and 164).
During the term of this Agreement, all Consultant's activities are undertaken and performed as an independent contractor and not an employee of Akari. Consultant shall not in any way represent themself to be an employee, partner, joint venturer, agent, or officer of or with Xxxxx. Consultant will be solely responsible for all federal, state, or local taxes, social security withholding, and other self-employment tax obligations as to payments made to Consultant under this Agreement.
The relationship of the Consultant with the Company will at all times be that of an independent contractor and not an employee or agent. Nothing in this Agreement will be construed to create a partnership, joint venture, agency or employment relationship between the Company and the Consultant. Unless authorized by the Board, Consultant will
2
not have the authority (and may not hold herself out as having authority) to bind the Company and to make agreements or representations on the Company’s behalf.
Akari shall not provide any retirement, medical health insurance or similar plans or worker’s compensation or any other benefit whatsoever to Consultant. Consultant shall have no claim against Akari hereunder or otherwise be eligible for or entitled to vacation pay, sick leave, retirement benefits, social security, worker’s compensation, health or disability benefits, unemployment insurance benefits, or any other employee benefits of any kind.
Consultant may not assign this Agreement or subcontract their obligations under it to another person or entity without Xxxxx's express written permission.
Consultant will not originate any publicity, news release, or other public announcement, written or oral relating to this Agreement, to any amendment to it, or to its performance without Xxxxx 's prior written consent.
3
Consultant represents that they have not been debarred by any relevant governmental or regulatory authority. Further, if Xxxxx allows Consultant to engage any other person or entity to perform any Services under this Agreement, Consultant represents that they will not engage a person or entity if they have been debarred.
Consultant shall comply with all applicable laws, rules, and regulations when performing the Services under this Agreement.
Any notice required or permitted under this Agreement shall be in writing and delivered by express mail or express delivery service to the Party at the address indicated below or at such other address as the addressee may have last furnished in writing to the addressor. The notice shall be effective upon receipt by the addressee.
If to Consultant: |
|
Board Advantage LLC |
|
|
[Street Address] |
|
|
[City, State, Zip] |
|
|
Attn: Xxxxx XxXxxxx |
If to Akari: |
|
Akari Therapeutics, Inc. |
|
|
00 Xxxxxx Xxxxx Xxxx XX 0 |
|
|
Boston, MA 02210 |
|
|
Attn: Xxxxxxxx Xxxxxxx, CEO |
This Agreement shall be governed by the laws of the Commonwealth of Massachusetts.
If any part of this Agreement is found unenforceable by a court of competent jurisdiction, the remainder of the Agreement shall nevertheless remain in full force and effect. Further, the unenforceable provision shall be construed by the court in such a manner as to give maximum effect to its intended meaning.
This Agreement is the entire agreement between Akari and Consultant as to its subject matter, and supersedes all prior representations or agreements, written or oral. This Agreement may be amended only by written instrument signed by both Parties.
4
This Agreement may be executed in two counterparts, and signature pages may be exchanged by facsimile or email.
In witness to their Agreement, the authorized representative of each party has signed it below.
AKARI THERAPEUTICS, INC. |
|
BOARD ADVANTAGE, LLC |
||||
|
|
|
|
|
|
|
By: |
|
/s/ Xxxxxxxx Xxxxxxx |
|
By: |
|
/s/ Xxxxx XxXxxxx |
|
|
|
|
|
|
|
Name: |
|
Xxxxxxxx Xxxxxxx |
|
Name: |
|
Xxxxx XxXxxxx |
|
|
|
|
|
|
|
Title |
|
President and CEO |
|
Title: |
|
Interim CFO |
|
|
|
|
|
|
|
Date: |
|
01/12/2024 |
|
Date: |
|
01/12/2024 |
5